All In Biotech

Free tool

FAERS Monitor: Xipere

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 211950 or its brand name (Xipere, Triamcinolone Acetonide). Reports on generic versions are filed under their own applications.

Reports

24,536

Serious

13,112

53% of reports

Hospitalization

6,275

Death reported

3,174

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,821
  • off label use2,879
  • pruritus2,715
  • rash2,558
  • pain2,133
  • fatigue2,033
  • nausea1,945
  • product use in unapproved indication1,739
  • diarrhoea1,704
  • vomiting1,703
  • condition aggravated1,678
  • headache1,621
  • arthralgia1,546
  • dizziness1,438
  • infusion related reaction1,419

Reports by year received

View as table
YearReports
200471
200558
200640
200780
2008116
2009109
2010113
2011177
2012175
2013203
2014227
2015465
2016633
2017802
20181,050
20191,206
20201,470
20211,789
20222,312
20232,747
20243,545
20253,865
20263,283

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,029,623 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion related reactionSignal1,41918.717.823,363
pruritusSignal2,7156.15.911,682
product use in unapproved indicationSignal1,7396.15.87,361
rashSignal2,5585.14.98,441
condition aggravatedSignal1,6784.84.55,012
arthralgiaSignal1,5463.23.02,368
vomitingSignal1,7033.13.02,487
painSignal2,1333.02.92,885
off label useSignal2,8792.82.73,527
drug ineffectiveSignal3,8212.52.43,621
dizzinessSignal1,4382.52.41,290
diarrhoeaSignal1,7042.32.21,239
fatigueSignal2,0332.22.21,447
headacheSignal1,6212.22.11,115
nauseaSignal1,9452.12.01,175

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.